Helicobacter pylori and gastroesophageal reflux disease: The bug may not be all bad

American Journal of Gastroenterology

Volumn 93, Issue 10, 1998, Pages 1800-1802

  Richter, Joel E ^a   Falk, Gary W ^a   Vaezi, Michael F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA;

ADENOCARCINOMA; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BARRETT ESOPHAGUS; GASTRITIS; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH CARCINOMA; STOMACH PH;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PREVALENCE;

EID: 0032446524     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00523.x     Document Type: Review

References (26)

1. 1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcerations. Lancet 1984;1:131-5.
2. 2. Vicari J, Falk GW, Richter JE. Helicobacter pylori and acid peptic disorders of the esophagus: Is it conceivable? Am J Gastroenterol 1997;92:1097-102.
3. 3. Locke GR, Talley NG, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmstead County, Minnesota. Gastroenterology 1997;112:1448-56.
4. 4. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315: 362-71.
5. 5. Blot WJ, Dervesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-9.
6. 6. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-90.
7. 7. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;114:633-9.
8. 8. Mitchell HM, Hazell SL, Li YY, et al. Serological response to specific Helicobacter pylori antigens: Antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996;91:1785-8.
9. 9. Chang CS, Poon SK, Lien HC, et al. The incidence of reflux esophagitis among the Chinese. Am J Gastroenterol 1997;92:668-71.
10. 10. Hesketh PJ, Clopp RW, Doos WG, et al. The increasing frequency of adenocarcinoma of the esophagus. Cancer 1989;64:526-30.
11. 11. Graham DY, Malaty HM, Evans DG, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100:1495-501.
12. 12. Grimley CE, Loft DE, Morris AG, et al. Virulent Helicobacter pylori in patients with gastric and esophageal adenocarcinoma. Gastroenterology 1997;112:A571 (abstract).
13. 13. Peek RM, Miller GG, Tham KT, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995;71:760-70.
14. 14. El-Omar EM, Penman ID, Ardill JE, et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995;109:681-91.
15. 15. Feldman M, Cryer B, McArthur KE, et al. Relationship between severity of H. pylori gastritis and gastric acid-pepsin secretion in man. Gastroenterology 1996;110:A106 (abstract).
16. 16. Espluges JV, Barrachina MD, Calatyud S, et al. Nitric oxide mediates the inhibition of interleukin-1 beta of pentagastrin-stimulated rat gastric acid secretion. Br J Pharmacol 1993;108:9-10.
17. 17. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: Biological and therapeutic implications. Gastroenterology 1996; 110:926-38.
18. 18. Kuipers EJ, Perez-Perez GI, Meuwissen GM, et al. Helicobacter pylori and atrophic gastritis: Importance of the cag A status. J National Cancer Inst 1985;87:1777-80.
19. 19. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113:15-24.
20. 20. Kuipers EJ, Lundell L, Klinkenberg-Knol E, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334: 1018-22.
21. 21. Bercik P, Verdu EF, Armstrong D, et al. H. pylori related increase in omeprazole is associated with ammonia production. Gastroenterology 1996;110:A64 (abstract).
22. 22. Labenz J, Blum AL, Bayendoffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer disease may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
23. 23. Malferheiner P, Veldhuzen van Zantan S, Dent J, et al. Does cure of Helicobacter pylori infection induce heartburn. Gastroenterology 1998;114:A212 (abstract).
24. 24. Talley NJ, Janssens J, Louritsen K, et al. No increase of reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo controlled trial. Gastroenterology 1998;114:A306 (abstract).
25. 25. Kobie T, Ohara S, Sekine H, et al. Increased of gastric acid secretion after H. pylori eradication caused the development of reflux esophagitis. Gastroenterology 1998;114:A183 (abstract).
26. 26. Komatsu Y, Kato M, Kudo T, et al. Examination of acute gastric erosion, duodenal erosion and reflux esophagitis after eradication of Helicobacter pylori. Gastroenterology 1998;114:A184 (abstract).